134 related articles for article (PubMed ID: 19377441)
1. Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors.
Hofer MD; Chang MC; Hirko KA; Rubin MA; Nosé V
Mod Pathol; 2009 Jul; 22(7):933-9. PubMed ID: 19377441
[TBL] [Abstract][Full Text] [Related]
2. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation.
Ohike N; Morohoshi T
Pathol Int; 2001 Oct; 51(10):770-7. PubMed ID: 11881729
[TBL] [Abstract][Full Text] [Related]
4. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis.
Ohike N; Morohoshi T
Endocr Pathol; 2005; 16(1):33-40. PubMed ID: 16000844
[TBL] [Abstract][Full Text] [Related]
5. Multihormonality and entrapment of islets in pancreatic endocrine tumors.
Kapran Y; Bauersfeld J; Anlauf M; Sipos B; Klöppel G
Virchows Arch; 2006 Apr; 448(4):394-8. PubMed ID: 16418841
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue.
Hofer MD; Tapia C; Browne TJ; Mirlacher M; Sauter G; Rubin MA
Arch Pathol Lab Med; 2006 Jul; 130(7):989-96. PubMed ID: 16831056
[TBL] [Abstract][Full Text] [Related]
7. KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers.
Zhang L; Smyrk TC; Oliveira AM; Lohse CM; Zhang S; Johnson MR; Lloyd RV
Am J Surg Pathol; 2009 Oct; 33(10):1562-9. PubMed ID: 19574886
[TBL] [Abstract][Full Text] [Related]
8. Update on pancreatic endocrine tumors.
Frankel WL
Arch Pathol Lab Med; 2006 Jul; 130(7):963-6. PubMed ID: 16831051
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer.
Li SH; Tian H; Yue WM; Li L; Gao C; Li WJ; Hu WS; Hao B
World J Surg; 2012 Mar; 36(3):623-31. PubMed ID: 22270988
[TBL] [Abstract][Full Text] [Related]
11. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors.
Figueiredo FA; Giovannini M; Monges G; Bories E; Pesenti C; Caillol F; Delpero JR
Gastrointest Endosc; 2009 Nov; 70(5):907-14. PubMed ID: 19640525
[TBL] [Abstract][Full Text] [Related]
12. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
Tomita T; Iwata K
Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis.
Ma K; Fan Y; Hu Y
Medicine (Baltimore); 2018 Oct; 97(41):e12292. PubMed ID: 30313027
[TBL] [Abstract][Full Text] [Related]
14. The Immunohistochemical Expression MTA 1 Protein and its Prognostic Value in Pancreatic Cancer.
Pavlidis ET; Lambropoulou M; Symeonidis NG; Anagnostopoulos C; Tsaroucha A; Kotini A; Nikolaidou C; Kiziridou A; Simopoulos C
J Invest Surg; 2018 Apr; 31(2):142-150. PubMed ID: 28635511
[TBL] [Abstract][Full Text] [Related]
15. CEACAM1 expression in pancreatic endocrine tumors.
Serra S; Asa SL; Bamberger AM; Wagener C; Chetty R
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):286-93. PubMed ID: 19349857
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer.
Liu T; Yang M; Yang S; Ge T; Gu L; Lou G
Hum Pathol; 2013 Oct; 44(10):2275-81. PubMed ID: 23866297
[TBL] [Abstract][Full Text] [Related]
17. Histidine decarboxylase expression in pancreatic endocrine cells and related tumors.
Tanimoto A; Matsuki Y; Tomita T; Sasaguri T; Shimajiri S; Sasaguri Y
Pathol Int; 2004 Jun; 54(6):408-12. PubMed ID: 15144399
[TBL] [Abstract][Full Text] [Related]
18. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Damaskos C; Koutsounas I; Zizi-Serbetzoglou A; Tsoukalas N; Patsouris E; Kouraklis G; Theocharis S
BMC Gastroenterol; 2015 Oct; 15():148. PubMed ID: 26502922
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors.
Rubbia-Brandt L; Terris B; Giostra E; Dousset B; Morel P; Pepper MS
Clin Cancer Res; 2004 Oct; 10(20):6919-28. PubMed ID: 15501970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
